as on
| Source : BSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
6.22%
Downside
0.03%
Upside
52 Week's Low
52 Week's High
14.38%
Downside
49.55%
Upside
Market Stats | |
Previous Close | ₹36.42 |
Open | ₹35.48 |
Volume | 504.00 |
Upper Circuit | ₹43.70 |
Lower Circuit | ₹29.14 |
Day's Low | ₹34.5 |
Day's High | ₹36.8 |
52 Week Low | ₹31.5 |
52 Week High | ₹55.02 |
Returns % | |
1 Month Return | -6.84 % |
3 Month Return | -17.05 % |
1 Year Return | + 8.21 % |
3 Year Return | + 9.82 % |
5 Year Return | -10.38 % |
Check Parmax Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹13.76 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
-0.19
P/B Ratio
178
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-7700
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Get the annual and quarterly financial summary of Parmax Pharma Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Parmax Pharma Ltd.
Parmax Pharma Ltd’s net profit fell -7700% since last year same period to ₹0.76Cr in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 48.99% jump in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Parmax Pharma Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 30.8% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 69.2% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Parmax Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 13.76 | -2.08% | 0.00 | -6 | 11 | |
NA | 355.90 | -5.99% | 0.69 | 5 | 1,684 | |
NA | 140.63 | 16.77% | 0.84 | 7 | 339 | |
NA | 979.15 | 294.15% | 0.74 | 7 | 1 | |
NA | 594.46 | 136.72% | 0.85 | -1 | 107 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 26.7% return, outperforming this stock by 18.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 30.80% of holdings in Jun 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 69.20% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 140.4% return, outperforming this stock by 130.5%
Price Dip
In the last 3 months, Parmax Pharma stock has moved down by -17.1%
Organisation | Parmax Pharma Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Parmax Pharma Ltd share price today stands at ₹36.79, Open: ₹35.48, Previous Close: ₹36.42, High: ₹36.8, Low: ₹34.5, 52 Week High: ₹55.02, 52 Week Low: ₹31.5 as on .
To buy Parmax Pharma Ltd shares, you need to follow these steps:
Today's traded volume of Parmax Pharma Ltd is 504.00. Which means that 504.00 shares of Parmax Pharma Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Parmax Pharma Ltd is ₹13.76 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Parmax Pharma Ltd’s 52 week high is ₹55.02 and 52 week low is ₹31.5. The current share price of Parmax Pharma Ltd is ₹36.79, which is -33.13% down from its 52 week high and 16.79% up from its 52 week low.